Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
19/03/2019 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3rd Party Publications
13/03/2019 Medicinal Product Shortages - update - 13 March 2019 Advisory
06/03/2019 HPRA IMF Article March 2019 3rd Party Publications
06/03/2019 Medicinal Product Shortages - update - 6 March 2019 Advisory
27/02/2019 Medicinal Product Shortages - update - 27 February 2019 Advisory
21/02/2019 Noradrenaline (Norepinephrine) - Important Safety Information from Laboratoire Aguettant as approved by the HPRA 3rd Party Publications
20/02/2019 Medicinal Product Shortages - update - 20 February 2019 Advisory
13/02/2019 Medicinal Product Shortages - update - 13 February 2019 Advisory
06/02/2019 Medicinal Product Shortages - update - 6 February 2019 Advisory
01/02/2019 Summary of Direct Healthcare Professional Communications (DHPCs) issued in January 2019 3rd Party Publications